Dr. Yuki Yoshimatsu | Nanoscale | Women Researcher Award
Dr. Yuki Yoshimatsu at Tochigi Cancer Center, Japan
Dr. Yuki Yoshimatsu is a leading cancer biologist and Project Leader at the Tochigi Cancer Center Research Institute, Japan. She holds a Ph.D. in Medical Science from the University of Tokyo and has extensive experience in rare cancer research, particularly sarcomas. Her career includes senior roles at the National Cancer Center Research Institute in Tokyo and postdoctoral training at the University of Washington, USA. Her research focuses on patient-derived cancer models, drug sensitivity screening, kinomic profiling, and biomarker discovery for precision oncology. She has established over 100 rare cancer models and contributed to national clinical guidelines. Dr. Yoshimatsu is also committed to mentoring young female scientists and advancing translational oncology through international collaboration.
Professional Profile:
Summary of Suitability for Women Researcher Award: Dr. Yuki Yoshimatsu
Dr. Yuki Yoshimatsu exemplifies excellence in biomedical research and leadership in translational oncology, making her a highly deserving candidate for the Women Researcher Award. With a Ph.D. in Medical Science from the University of Tokyo and extensive research experience at prestigious institutions including the National Cancer Center Japan and the University of Washington, Dr. Yoshimatsu has established herself as a leading figure in rare cancer biology.
๐ Education
Ph.D. in Medical Science
๐๏ธ University of Tokyo, Graduate School of Medicine
๐งฌ Department of Pathology
๐ Tokyo, Japan
๐ผ Professional Experience
Project Leader
๐ฅ Tochigi Cancer Center Research Institute
๐ Tochigi, Japan | โณ 2022 โ Present
๐ฌ Leading translational research in rare cancers and biomarker development
Senior Researcher
๐งช National Cancer Center Research Institute
๐ Tokyo, Japan | โณ 2016 โ 2022
๐งซ Established multiple patient-derived sarcoma models and conducted drug sensitivity profiling
Postdoctoral Fellow
๐งฌ University of Washington, Dept. of Otolaryngology
๐ Seattle, WA, USA | โณ 2012 โ 2016
๐ International research in viral oncogenesis and multi-step carcinogenesis
๐งช Research Interests
๐งซ Rare cancers (esp. sarcomas)
๐งฌ Patient-derived cancer models (cell lines, organoids, xenografts)
๐ Drug sensitivity screening & kinomic profiling
๐ง Biomarker discovery for precision oncology
๐ฆ Viral oncogenesis & multi-step carcinogenesis
๐ Honors & Awards
๐ฅ Best Presentation Award
โEstablishment and characterization of a novel leiomyosarcoma cell lineโ
๐
Aug 2023 | ๐งฌ Japanese Society of Human Cell Science
๐
Poster Award
โConstruction of patient-derived sarcoma modelsโ
๐
Nov 2021 | ๐ฌ Japan Society for Patient-Derived Cancer Models
๐ International Research Grant
โMechanisms of multi-step carcinogenesis in cervical cancerโ
๐
Mar 2010 | ๐งช Kanzawa Medical Research Promotion Foundation
Publication Top Notes
Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans
Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1